Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $287.31 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $111.54 | 6 | $0 (2018) |
| Shire North American Group Inc | $84.64 | 4 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $31.71 | 1 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $24.80 | 1 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $17.47 | 1 | $0 (2017) |
| Orexo US, Inc. | $17.15 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $29.55 | 2 | Sunovion Pharmaceuticals Inc. ($29.55) |
| 2017 | $257.76 | 12 | Shire North American Group Inc ($84.64) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/27/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: CNS | ||||||
| 10/19/2018 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: CNS | ||||||
| 12/19/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.68 | General |
| Category: CNS | ||||||
| 12/04/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $22.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: CNS | ||||||
| 10/09/2017 | Teva Pharmaceuticals USA, Inc. | SD809-TD (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Central Nervous System | ||||||
| 09/26/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: PSYCHIATRY | ||||||
| 09/05/2017 | Shire North American Group Inc | MYDAYIS (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: CNS | ||||||
| 04/25/2017 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $31.71 | General |
| 04/25/2017 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2017 | Orexo US, Inc. | Zubsolv (Drug) | Food and Beverage | Cash or cash equivalent | $17.15 | General |
| Category: Addiction Medicine | ||||||
| 01/24/2017 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: NEUROSCIENCE | ||||||
| 01/11/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 24 | 53 | $3,074 | $2,245 |
| 2022 | 1 | 17 | 29 | $1,562 | $960.15 |
| 2020 | 1 | 13 | 17 | $808.00 | $595.64 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 53 | $3,074 | $2,245 | 73.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 17 | 29 | $1,562 | $960.15 | 61.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 13 | 17 | $808.00 | $595.64 | 73.7% |
About Dr. Manjula Kumar, M.D
Dr. Manjula Kumar, M.D is a Psychiatry healthcare provider based in Morris Plains, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831267350.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manjula Kumar, M.D has received a total of $287.31 in payments from pharmaceutical and medical device companies, with $29.55 received in 2018. These payments were reported across 14 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($287.31).
As a Medicare-enrolled provider, Kumar has provided services to 54 Medicare beneficiaries, totaling 99 services with total Medicare billing of $3,801. Data is available for 3 years (2020–2023), covering 3 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Morris Plains, NJ
- Active Since 12/01/2006
- Last Updated 04/02/2012
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831267350
Products in Payments
- LATUDA (Drug) $111.54
- MYDAYIS (Drug) $43.83
- VYVANSE (Drug) $40.81
- ABILIFY MAINTENA (Drug) $24.80
- SD809-TD (Drug) $17.47
- Zubsolv (Drug) $17.15
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Morris Plains
Dr. Elda Sancho Mora, M.d, M.D
Psychiatry — Payments: $1,189
Joselito Domingo, M.d, M.D
Psychiatry — Payments: $808.40
Dr. Edward Collopy, M.d, M.D
Psychiatry — Payments: $222.70
Marie Rabanal, M.d, M.D
Psychiatry — Payments: $178.73
Dr. Inderpal Bhathal, Md, MD
Psychiatry — Payments: $85.03
Dr. David Mayerhoff, M.d, M.D
Psychiatry — Payments: $31.74